This Week in Pediatrics
FDA news in pediatrics: August 2026 | Contemporary Pediatrics
On August 19, 2026, the FDA accepted Teva's New Drug Application and granted priority review to ecopipam, a first-in-class selective dopamine D1 receptor antagonist, for pediatric Tourette syndrome, with a target action date in late Q1 2027.
Contemporary Pediatrics – Clinical News & Pediatrician Practice Tips
Chronic skin conditions linked to bullying, depression, and suicide risk in children, adolescents · Chronic pediatric skin disorders cause significant stigma, bullying, depression, and suicide risk—conditions often underrecognized and ...
Fall vaccines 2026: What to know about flu, Covid and RSV | CNN
Children younger than 8 months should be immunized against RSV using a monoclonal antibody unless their mother got an RSV vaccination during pregnancy, said Dr. Andrew Racine, president of the American Academy of Pediatrics.
Research of the Day
Early Antibiotic Exposure and Neurodevelopmental Outcomes: A Population-Based Cohort Study
This large population-based cohort study examined over 1.2 million children to investigate the association between antibiotic exposure in the first year of life and subsequent neurodevelopmental outcomes. The researchers found a modest but statistically significant association between early broad-spectrum antibiotic use and increased risk of ADHD and autism spectrum disorder diagnoses, though the absolute risk increase remained small.
Key findings include: (1) Children exposed to antibiotics in the first year had a 12% increased relative risk of ADHD diagnosis; (2) The association was stronger with repeated courses of broad-spectrum antibiotics; (3) The effect persisted after adjusting for maternal infections and other confounders.
While the study shows an association, causation is not established. The findings support judicious antibiotic use in infants—prescribing when clinically indicated, but avoiding unnecessary courses.
Popular Beliefs
Cracking knuckles causes arthritis
What the evidence shows: Studies comparing habitual knuckle-crackers to non-crackers found no increased arthritis risk. The cracking sound is from gas bubble release in synovial fluid. The main consequence may be reduced grip strength and annoyed family members.
Reading to babies is pointless—they don't understand
What the evidence shows: Research consistently demonstrates that reading to infants from birth supports language development, vocabulary acquisition, and later literacy skills. Even before understanding words, babies benefit from hearing language patterns, rhythm, and the bonding experience. The AAP recommends reading aloud beginning in infancy.
Shaving makes hair grow back thicker and darker
What the evidence shows: Shaving removes hair at the skin surface, leaving a blunt tip that may feel coarser as it grows out. However, it does not affect hair thickness, color, or growth rate. This is an optical illusion from the blunt vs. tapered hair shaft.
Behaviors
Media Multitasking and Attention in Adolescents
This study of 600 high school students examined the relationship between media multitasking (using multiple screens simultaneously) and attention abilities. Heavy media multitaskers showed reduced ability to filter irrelevant information.
Key findings: (1) Heavy multitaskers had 15% more attention lapses in class; (2) Greater difficulty switching between tasks effectively; (3) Sleep quality mediated some of the relationship.
Counsel adolescents (and parents) on single-tasking for homework. Having phone notifications off and single-device focus improves learning efficiency and quality.
Genetics
Gene Therapy Shows Promise for Spinal Muscular Atrophy Type 1
Long-term follow-up data from the Phase 3 clinical trial of onasemnogene abeparvovec gene therapy reveals sustained motor milestone achievements in children with SMA Type 1 treated before 6 months of age. At 5-year follow-up, 94% of early-treated patients maintained the ability to sit independently, and 68% achieved independent walking—outcomes historically unprecedented in untreated SMA Type 1.
The study also reports on safety outcomes, with no new treatment-related serious adverse events emerging after year 2. These results strengthen the case for newborn screening and early intervention in SMA.
This data reinforces the critical importance of early diagnosis and treatment in SMA. Support newborn screening initiatives in your state. For families with SMA history, discuss carrier testing and ensure rapid referral to neuromuscular specialists if symptoms arise.